DR Horton Share Price

Equities

DHI

US23331A1097

Homebuilding

Market Closed - Nyse 01:30:02 01/06/2024 am IST 5-day change 1st Jan Change
147.8 USD +1.59% Intraday chart for DR Horton +2.20% -2.75%
Sales 2024 * 3.69TCr 3,08000Cr Sales 2025 * 3.94TCr 3,28600Cr Capitalization 4.87TCr 4,06000Cr
Net income 2024 * 472Cr 39TCr Net income 2025 * 500.4Cr 42TCr EV / Sales 2024 * 1.36 x
Net Debt 2024 * 136.22Cr 11TCr Net Debt 2025 * 102.05Cr 8.51TCr EV / Sales 2025 * 1.26 x
P/E ratio 2024 *
10.4 x
P/E ratio 2025 *
9.51 x
Employees 13,450
Yield 2024 *
0.81%
Yield 2025 *
0.87%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.59%
1 week+2.20%
1 month+1.61%
3 months-3.38%
6 months+12.95%
Current year-2.75%
More quotes
1 week
140.42
Extreme 140.42
148.08
1 month
140.42
Extreme 140.42
157.73
Current year
138.83
Extreme 138.83
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01/99/01
Chairman 68 01/88/01
Director of Finance/CFO 58 01/98/01
Members of the board TitleAgeSince
Director of Finance/CFO 58 01/98/01
Director/Board Member 78 23/14/23
Director/Board Member 73 20/21/20
More insiders
Date Price Change Volume
31/24/31 147.8 +1.59% 4,213,675
30/24/30 145.5 +2.91% 1,809,355
29/24/29 141.4 -1.03% 1,850,407
28/24/28 142.8 -1.22% 1,341,075

Delayed Quote Nyse, May 01, 2024 at 01:30 am IST

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.8 USD
Average target price
169.8 USD
Spread / Average Target
+14.89%
Consensus